RANDOMIZED TRIAL OF LIMUS-ELUTING STENTS WITH BIODEGRADABLE OR PERMANENT POLYMER COATINGS REGARDING STENT COVERAGE ASSESSED BY OPTICAL COHERENCE TOMOGRAPHY.
Phase of Trial: Phase IV
Latest Information Update: 01 Mar 2014
At a glance
- Drugs Everolimus (Primary)
- Indications Coronary artery disease; Coronary artery restenosis; Myocardial ischaemia
- Focus Therapeutic Use
- Acronyms TEST-6-OCT
- 04 Jan 2012 Actual patient number is 48 according to ClinicalTrials.gov.
- 04 Jan 2012 Actual end date (May 2011) added as reported by ClinicalTrials.gov.
- 04 Jan 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.